Puig, Fernando S.

HRN: 01-66-47  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
CEFTAZIDIME 1GM (VIAL)
10/25/2022
11/01/2022
IV
1 GRAM
Q8HRS
CAP-MR; PRESUMPTIVE PTB
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: